Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
- PMID: 15820810
- DOI: 10.1016/j.fertnstert.2004.11.029
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
Abstract
Objective: The aim of this study was to assess which of the basal ovarian reserve markers provides the best reflection of the changes occurring in ovarian function over time (i.e., reproductive aging).
Design: Prospective longitudinal study.
Setting: Healthy volunteers in an academic research center.
Patient(s): Eighty-one women with normal reproductive performance during the course of their lives were longitudinally assessed. In this select group of women, becoming chronologically older was considered as a proxy variable for becoming older from a reproductive point of view.
Intervention(s): The women were assessed twice, with on average a 4-year interval (T(1) and T(2)). The number of antral follicles on ultrasound (AFC) and blood levels of antimullerian hormone (AMH), FSH, inhibin B, and E(2) were assessed.
Main outcome measure(s): Longitudinal changes of the markers mentioned and the consistency of these parameters over time.
Result(s): The mean ages at T(1) and T(2) were 39.6 and 43.6 years, respectively. Although AFC was strongly associated with age in a cross-sectional fashion, it did not change over time. The AMH, FSH, and inhibin B levels showed a significant change over time, in contrast to E(2) levels. The AMH and AFC were highly correlated with age both at T(1) and T(2), whereas FSH and inhibin B predominantly changed in women more than 40 years of age. To assess the consistency of these parameters over time, we investigated whether a woman's individual level above or below the mean of her age group at T(1) remained above or below the mean of her age group at T(2). Serum AMH concentrations showed the best consistency, with AFC as second best. The FSH and inhibin B showed only modest consistency, whereas E(2) showed no consistency at all.
Conclusion(s): These results indicate that serum AMH represents the best endocrine marker to assess the age-related decline of reproductive capacity.
Similar articles
-
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.Fertil Steril. 2004 Nov;82(5):1323-9. doi: 10.1016/j.fertnstert.2004.03.061. Fertil Steril. 2004. PMID: 15533354
-
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?BJOG. 2005 Oct;112(10):1384-90. doi: 10.1111/j.1471-0528.2005.00670.x. BJOG. 2005. PMID: 16167941
-
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.Hum Reprod. 2005 Jul;20(7):1820-6. doi: 10.1093/humrep/deh850. Epub 2005 Mar 31. Hum Reprod. 2005. PMID: 15802325
-
Anti-Müllerian hormone: a new marker for ovarian function.Reproduction. 2006 Jan;131(1):1-9. doi: 10.1530/rep.1.00529. Reproduction. 2006. PMID: 16388003 Review.
-
Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?Clin Endocrinol (Oxf). 2006 Jun;64(6):603-10. doi: 10.1111/j.1365-2265.2006.02533.x. Clin Endocrinol (Oxf). 2006. PMID: 16712660 Review.
Cited by
-
Effect of Laparoscopic Ovarian Cystectomy on Ovarian Reserve in Benign Ovarian Cysts.J Hum Reprod Sci. 2021 Jan-Mar;14(1):56-60. doi: 10.4103/jhrs.JHRS_94_20. Epub 2021 Mar 30. J Hum Reprod Sci. 2021. PMID: 34083993 Free PMC article.
-
Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications.J Clin Oncol. 2013 Mar 20;31(9):1239-47. doi: 10.1200/JCO.2012.43.5511. Epub 2013 Feb 4. J Clin Oncol. 2013. PMID: 23382474 Free PMC article. Review.
-
Maternal antimullerian hormone levels do not predict fetal aneuploidy.J Assist Reprod Genet. 2010 Jul;27(7):409-14. doi: 10.1007/s10815-010-9433-4. Epub 2010 May 20. J Assist Reprod Genet. 2010. PMID: 20490648 Free PMC article.
-
Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.J Clin Endocrinol Metab. 2013 Dec;98(12):4629-38. doi: 10.1210/jc.2013-2375. Epub 2013 Sep 24. J Clin Endocrinol Metab. 2013. PMID: 24064685 Free PMC article.
-
Anti-mullerian hormone: a new marker of ovarian function.J Obstet Gynaecol India. 2014 Apr;64(2):130-3. doi: 10.1007/s13224-013-0482-3. Epub 2013 Dec 3. J Obstet Gynaecol India. 2014. PMID: 24757342 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical